Fig. 6From: Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signatureThe nomogram developed based on the C-R-R model, which incorporated the Necrosis, SF, TLG, LDH and Rad score. It is used to non-invasively predict MYCN amplification in paediatric neuroblastoma patients. C-R-R, clinical-radiological-radiomics; SF, serum ferritin; TLG, total lesion glycolysis; LDH, lactate dehydrogenaseBack to article page